Prelude Therapeutics Inc

NASDAQ:PRLD   1:00:00 PM EDT
0.79
-0.01 (-0.76%)
2:45:39 PM EDT: $0.78 -0.01 (-1.75%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Prelude Therapeutics Inc Stock, NASDAQ:PRLD

175 Innovation Boulevard, Wilmington, Delaware 19805
United States of America
Phone: +1.302.467.1280
Number of Employees: 131
http://www.preludetx.com

Description

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.